GlassScriptPhysician profile
Gautham P Reddy
NPI 1942205653
$1,122.93
in general payments reported to CMS, 2019-2025
26 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.61 · 2021: $196 · 2022: $126 · 2023: $315 · 2024: $201 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $621.81 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $168.31 | 2021-2023 | Tysabri |
| Neurocrine Biosciences, INC. | $125.00 | 2025 | |
| Lundbeck LLC | $83.09 | 2021-2024 | Vyepti |
| Argenx US, INC. | $67.38 | 2022-2023 | Vyvgart |
| Ucb, INC. | $65.39 | 2021-2024 | Rystiggo |
| Abbvie INC. | $59.35 | 2021-2024 | |
| Tg Therapeutics, INC. | $58.59 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $55.54 | 2024 | |
| Globus Medical, INC. | $54.68 | 2025 | Senza |
| Medtronic, INC. | $50.80 | 2022-2024 | Abre, Synchromedii |
| Microtransponder, INC. | $42.60 | 2025 | |
| Pfizer INC. | $34.77 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $33.63 | 2025 | Xeomin |
| Janssen Pharmaceuticals, INC | $21.72 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $21.02 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $19.95 | 2022 | |
| Genentech USA, INC. | $19.54 | 2024 | Ocrevus Zunovo, Ocrevus |
| Banner Life Sciences, LLC | $19.48 | 2023 | |
| Allergan, INC. | $19.17 | 2021 | |
| Kyowa Kirin, INC. | $18.55 | 2023 | Nourianz |
| Horizon Therapeutics Plc | $18.04 | 2022 | |
| Siemens Medical Solutions USA, INC. | $16.17 | 2023 | Magnetom Altea |
| Amylyx Pharmaceuticals, INC. | $14.13 | 2024 | Relyvrio |
| Ge Healthcare | $12.72 | 2023 | |
| Alexion Pharmaceuticals, INC. | $11.91 | 2021 | |
| Medtronic USA, INC. | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gautham Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.